Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 785, pseudogene (RN7SL785P)

Target
RN7SL785P
Molecular classification
Other, Processed pseudogene, Non-coding RNA (pseudogene), Not an enzyme, receptor, transporter, or other canonical drug target class
01

Overview

**RNA, 7SL, cytoplasmic 785, pseudogene (RN7SL785P)** is a *processed pseudogene*—a nonfunctional genomic DNA sequence resembling the functional 7SL RNA gene but lacking the ability to produce a functional RNA or protein product[1][6][8][9]. The 7SL RNA itself is a critical non-coding RNA component of the signal recognition particle, involved in protein targeting to membranes, but RN7SL785P represents a truncated and nonfunctional copy that arose through reverse transcription and integration into the genome[1][3][8][9]. Such pseudogenes do not generally serve as drug targets or have established direct roles in disease; their primary relevance is evolutionary and genomic, and they are not suitable for therapeutic intervention or biomarker development[6][8][9]. While some pseudogenes in other contexts can act as regulatory non-coding RNAs (for example, as miRNA sponges), no such function is known for RN7SL785P specifically[4].

Other names
RN7SL785P
02

Mechanism of action

None known

03

Biological functions

None established for this pseudogenePseudogene may rarely be transcribed, but no direct functional role is recognized
04

Disease associations

Other (no established or direct disease association for this specific pseudogene)Some evidence exists in broader literature for pseudogenes to act as non-coding RNA regulators in general, but RN7SL785P specifically is not known to have such a role[4][6]

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 785, pseudogene (RN7SL785P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 785, pseudogene (RN7SL785P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call